SkinHealth Systems Inc. (SKIN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

SkinHealth Systems Inc. (SKIN) Soars 9.0%: Is Further Upside Left in the Stock?

Key PointsBoth Danaher and GE Healthcare are trading at attractive valuations after recent declines.

2 Beaten-Down Healthcare Stocks That Could Soar in the Fourth Quarter

(RTTNews) - Danaher Corp. (DHR), a science and technology company, on Wednesday announced a collaboration with NVIDIA Corp.(NVDA)to advance autonomous science and accelerate scientific discovery.

Danaher Collaborates With NVIDIA To Advance AI-Powered Autonomous Science 

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the State Street Health Care Select Sector SPDR ETF (Symbol: XLV) where we have detected an approximate $378.4 million dollar inflow -- that's a 0.9% inc

Notable ETF Inflow Detected - XLV, DHR, BMY, CVS

(RTTNews) - Danaher Corp. (DHR), a healthcare company, said Thursday that Julie Sawyer Montgomery has assumed the roles of President and Chief Executive Officer and joined the company's Board, effective today.

Danaher CEO Julie Sawyer Montgomery Assumes Role 

Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the VictoryShares Free Cash Flow ETF, where 46,260,000 units were destroyed, or a 17.9% decrease week over week.  Among the largest underlying c

 VFLO, MVAL: Big ETF Outflows  

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.

Danaher Corporation News